CTS - CTS Corporation
| Previous Close | 27.38 |
| Open | 27.65 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's Range | 26.93 - 27.80 |
| 52 Week Range | 25.08 - 39.20 |
| Volume | 198,215 |
| Avg. Volume | 163,123 |
| Market Cap | 892.356M |
| Beta (3Y Monthly) | 1.88 |
| PE Ratio (TTM) | 61.02 |
| EPS (TTM) | 0.44 |
| Earnings Date | Oct 26, 2017 - Oct 30, 2017 |
| Forward Dividend & Yield | 0.16 (0.59%) |
| Ex-Dividend Date | 2018-12-27 |
| 1y Target Est | 33.00 |
- CNW Group•yesterday
Converge Achieves Cisco® Gold Certification
TORONTO , Nov. 13, 2018 /CNW/ - Converge Technology Solutions Corp. ("Converge" or "Company") is pleased to announce that it has achieved the Cisco® Gold Certification. This certification recognizes Cisco® partners who have proven their ability to empower business outcomes by implementing and supporting Cisco® technologies and following the Cisco® Lifecycle Services approach.
- Simply Wall St.•yesterday
Does The CTS Corporation (NYSE:CTS) Share Price Tend To Follow The Market?
Anyone researching CTS Corporation (NYSE:CTS) might want to consider the historical volatility of the share price. Volatility is considered to be a measure of risk in modern finance theory. Investors Read More...
- CNW Group•6 days ago
Converge Technology Solutions Corp. Announces Completion of Qualifying Transaction and Concurrent Financing
Converge Technology Solutions Corp. Announces Completion of Qualifying Transaction and Concurrent Financing
- GlobeNewswire•7 days ago
CTS Corporation Declares a Dividend
LISLE, Ill., Nov. 08, 2018 -- The Board of Directors of CTS Corporation (NYSE: CTS) declared a cash dividend of $0.04 per share, payable February 1, 2019, to shareholders of.
- GlobeNewswire•16 days ago
New Research Coverage Highlights HomeStreet, Cousins Properties, Carbo Ceramics, Cowen Group, CTS, and NovoCure — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, Oct. 30, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
- Thomson Reuters StreetEvents•16 days ago
Edited Transcript of CTS earnings conference call or presentation 25-Oct-18 3:00pm GMT
Q3 2018 CTS Corp Earnings Call
- Associated Press•21 days ago
CTS: 3Q Earnings Snapshot
On a per-share basis, the Lisle, Illinois-based company said it had net income of 30 cents. Earnings, adjusted for non-recurring costs and restructuring costs, came to 39 cents per share. The electronics ...
- GlobeNewswire•21 days ago
CTS Announces Third Quarter 2018 Results
Strong sales and earnings LISLE, Ill., Oct. 25, 2018 -- CTS Corporation (NYSE: CTS) today announced third quarter 2018 results. Sales were $118.9 million, up 11.9%.
- GlobeNewswire•22 days ago
CTS to Present at Baird’s 2018 Global Industrial Conference
LISLE, Ill., Oct. 23, 2018 -- CTS Corporation (NYSE: CTS) will be presenting at the Baird’s 2018 Global Industrial Conference on November 6, 2018 at 10:00 a.m. (CST) at the.
- GlobeNewswire•last month
CTS Corporation Announces Dates for Third Quarter 2018 Earnings Release and Conference Call
LISLE, Ill., Oct. 15, 2018 -- CTS Corporation (NYSE: CTS) will release earnings for the third quarter 2018 at approximately 8:00 a.m. (EDT) on Thursday, October 25, 2018. A.
- Simply Wall St.•last month
Will CTS Corporation (NYSE:CTS) Continue To Underperform Its Industry?
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it Read More...
- Zacks•2 months ago
Electronics Components Outlook: Growth Inherent Amid Trade Spat
Electronics Components Outlook: Growth Inherent Amid Trade Spat
- GlobeNewswire•2 months ago
CTS to Present at the Sidoti & Company Fall 2018 Conference
LISLE, Ill., Sept. 17, 2018-- CTS Corporation will be presenting at the Sidoti & Company Fall 2018 Conference on September 27, 2018 at 9:45 a.m. at the New York City Grand Hyatt. Additional information ...
- Simply Wall St.•2 months ago
Is CTS Corporation’s (NYSE:CTS) Balance Sheet Strong Enough To Weather A Storm?
Investors are always looking for growth in small-cap stocks like CTS Corporation (NYSE:CTS), with a market cap of US$1.20b. However, an important fact which most ignore is: how financially healthyRead More...
- GlobeNewswire•3 months ago
New Research: Key Drivers of Growth for REGENXBIO, Syndax Pharmaceuticals, Rowan Companies, CTS, Basic Energy Services, and Impinj — Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, Aug. 27, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of REGENXBIO ...
- GlobeNewswire•3 months ago
CTS Corporation Declares a Dividend
LISLE, Ill., Aug. 23, 2018-- The Board of Directors of CTS Corporation declared a cash dividend of $0.04 per share, payable November 2, 2018, to shareholders of record at the close of business on September ...
- Thomson Reuters StreetEvents•4 months ago
Edited Transcript of CTS earnings conference call or presentation 26-Jul-18 3:00pm GMT
Q2 2018 CTS Corp Earnings Call
- Associated Press•4 months ago
CTS: 2Q Earnings Snapshot
On a per-share basis, the Lisle, Illinois-based company said it had profit of 21 cents. Earnings, adjusted for non-recurring costs and pretax expenses, were 39 cents per share. The electronics manufacturer ...
- PR Newswire•4 months ago
Kodiak Sciences Appoints Bassil I. Dahiyat, Ph.D. Robert A. Profusek, J.D. and Richard S. Levy, M.D. to its Board of Directors
PALO ALTO, Calif., July 18, 2018 /PRNewswire/ -- Kodiak Sciences Inc., a clinical stage biopharmaceutical company specializing in novel therapeutics to treat high prevalence ophthalmic diseases, today announced the appointments of Bassil I. Dahiyat, Ph.D., Robert A. Profusek, J.D., and Richard S. Levy, M.D. to its Board of Directors. Dr. Dahiyat is the co-founder of Xencor (XNCR), a biopharmaceutical company, and has been its President and Chief Executive Officer since the Company's incorporation in August 1997. Dr. Dahiyat is a co-inventor of Xencor's breakthrough XmAb® antibody engineering technology. He has led Xencor in raising over $700 million in public and private financing, creating a diverse portfolio of monoclonal antibody clinical programs for the treatment of life-threatening and debilitating diseases and establishing alliances with leading biopharmaceutical companies that generated over $200 million in upfront payments. Dr. Dahiyat holds a Ph.D. in Chemistry from Caltech and B.S. and M.S.E. degrees in Biomedical Engineering from the Johns Hopkins University. He has co-authored numerous scientific papers in the fields of protein design and drug delivery, is an inventor of 33 US and numerous foreign patents and has received scientific awards from the American Chemical Society, the Controlled Release Society, the Protein Society and Caltech.
- Reuters•5 months ago
BRIEF-CTS International Logistics Signs Strategic Framework Agreement With JD Logistics' Trading Firm
June 28 (Reuters) - CTS International Logistics Corp Ltd : * SAYS IT SIGNS STRATEGIC COOPERATION FRAMEWORK AGREEMENT WITH JD LOGISTICS' TRADING FIRM Source text in Chinese: https://bit.ly/2ICIV9A Further ...
- Simply Wall St.•5 months ago
Is CTS Corporation’s (NYSE:CTS) Balance Sheet Strong Enough To Weather A Storm?
Investors are always looking for growth in small-cap stocks like CTS Corporation (NYSE:CTS), with a market cap of US$1.15b. However, an important fact which most ignore is: how financially healthyRead More...
- Reuters•5 months ago
BRIEF-CTS International Logistics To Set Up In SPV With Partners To Invest In Jingdong Express
June 22 (Reuters) - CTS International Logistics Corp Ltd : * SAYS UNIT PLANS TO INVEST $41.6 MILLION TO SET UP SPV WITH YULONGHE CAPITAL MANAGEMENT, HANJIANG INVESTMENT * SAYS THE SPV WILL INVEST $90 MILLION ...
